ClinConnect ClinConnect Logo
Search / Trial NCT05288959

Modeling TMS-induced Cortical Network Activity

Launched by MASSACHUSETTS GENERAL HOSPITAL · Mar 11, 2022

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

Human Brain Connectivity Paired Associative Stimulation Tms Eeg

ClinConnect Summary

This clinical trial is studying how different parts of the brain connect and communicate with each other in healthy individuals. Researchers will use a non-invasive technique called transcranial magnetic stimulation (TMS) to stimulate specific brain areas while also measuring brain activity with a method called electroencephalography (EEG). By doing this, they hope to learn how quickly signals travel between brain regions and how stimulating two areas at once might affect their connection.

To participate in this study, you need to be a healthy adult between the ages of 18 and 75, with normal hearing and vision, and able to give your consent to join the trial. However, certain conditions would prevent you from participating, such as having metal implants in your body, a history of seizures, or certain medical devices like pacemakers. If you join the study, you can expect a safe and non-invasive experience where your brain's activity is monitored while researchers explore how it functions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy
  • Normal hearing and (corrected) vision
  • Able to understand and give informed consent
  • Exclusion Criteria:
  • Metal in the body (rods, plates, screws, shrapnel, dentures, IUD)
  • Metallic particles in the eye
  • Surgical clips in the head or previous neurosurgery
  • Cardiac pacemaker or pacemaker wires
  • Neurostimulators
  • Implanted pumps
  • Any magnetic particles in the body
  • Cochlear implants
  • Prosthetic heart valves
  • Epilepsy or any other type of seizure history
  • Significant claustrophobia
  • Meniere's disease
  • Pregnancy or breast-feeding
  • Diagnoses or medications (neurological or psychiatric) influencing brain function
  • History of, or current, substance abuse
  • History of developmental disorders (e.g., dyslexia)
  • Failure to perform the behavioral tasks
  • Prisoners

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Charlestown, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Aapo Nummenmaa, PhD

Study Director

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials